Search

Your search keyword '"Huang, Li-Wen"' showing total 11 results
Start Over Author "Huang, Li-Wen" Publisher wiley
11 results on '"Huang, Li-Wen"'

1. Impact of 23‐valent pneumococcal polysaccharide vaccination on the frequency of pneumonia‐related hospitalization and survival in elderly patients with prostate cancer: A seven‐year nationwide matched cohort study

Author

Li, Chung‐Yi, primary, Chen, Liang‐Cheng, additional, Lin, Hon‐Yi, additional, Lee, Moon‐Sing, additional, Hung, Shih‐Kai, additional, Lai, Chun‐Liang, additional, Huang, Li‐Wen, additional, Yu, Ben‐Hui, additional, Hsu, Feng‐Chun, additional, and Chiou, Wen‐Yen, additional

Published
2020
Full Text
View/download PDF

5. Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma

Author

Huang, Li-Wen, primary, Bacon, Wendi, additional, Cirrincione, Constance, additional, Peterson, Bercedis, additional, Long, Gwynn, additional, Rizzieri, David, additional, Sullivan, Keith M., additional, Corbet, Kelly, additional, Horwitz, Mitchell, additional, Chao, Nelson, additional, Gasparetto, Cristina, additional, and Tuchman, Sascha A., additional

Published
2017
Full Text
View/download PDF

8. Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma

Author

Tuchman, Sascha A, primary, Bacon, Wendi A, additional, Huang, Li-Wen, additional, Long, Gwynn, additional, Rizzieri, David, additional, Horwitz, Mitchell, additional, Chute, John P., additional, Sullivan, Keith, additional, Morris Engemann, Ashley, additional, Yopp, Amanda, additional, Li, Zhiguo, additional, Corbet, Kelly, additional, Chao, Nelson, additional, and Gasparetto, Cristina, additional

Published
2014
Full Text
View/download PDF

11. Impact of 23-valent pneumococcal polysaccharide vaccination on the frequency of pneumonia-related hospitalization and survival in elderly patients with prostate cancer: A seven-year nationwide matched cohort study.

Author

Li CY, Chen LC, Lin HY, Lee MS, Hung SK, Lai CL, Huang LW, Yu BH, Hsu FC, and Chiou WY

Subjects
Aged, Aged, 80 and over, Cohort Studies, Hospitalization, Humans, Male, Pneumococcal Vaccines pharmacology, Prostatic Neoplasms mortality, Survival Analysis, Time Factors, Pneumococcal Vaccines therapeutic use, Pneumonia chemically induced, Prostatic Neoplasms drug therapy
Abstract

Background: The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is indicated for adults who have a high risk of pneumonia; however, its effectiveness in patients with prostate cancer who are at a risk of pneumonia because of age and cancer treatments, including androgen-deprivation therapy, is unknown., Methods: Between 2000 and 2010, 38,735 patients with prostate cancer were diagnosed in Taiwan. After exclusions and exact matching for age, previous pneumonia, and influenza vaccination, 2188 vaccinated patients and 2188 unvaccinated patients were recruited. The incidence density of all-cause bacterial pneumonia hospitalizations was analyzed., Results: Over 7 years of follow-up, patients who received the PPSV23 had a significantly lower incidence density, with 142.8 per 1000 person-years versus 162.0 per 1000 person-years for unvaccinated patients. More patients in the vaccinated cohort were never hospitalized for pneumonia compared with those in the unvaccinated cohort (64.2% vs 62.2%, respectively). After adjusting for the Charlson comorbidity index, cancer treatment modalities, and socioeconomic levels, the risk of pneumonia-related hospitalization in the PPSV23 vaccination cohort was 0.48 times lower than that in the unvaccinated cohort (adjusted incidence rate ratio, 0.48; P = .046). For patients who received the influenza vaccination, subgroup analysis demonstrated that PPSV23 vaccination significantly decreased the risk (adjusted incidence rate ratio, 0.45; P < .001). Compared with unvaccinated controls, PPSV23-vaccinated patients had a lower cumulative incidence for the first occurrence of pneumonia-related hospitalization (34.49% vs 36.36%; P = .178) and higher overall survival (47.5% and 42.3%, respectively; P < .001)., Conclusions: Vaccination of elderly patients who have prostate cancer with the relatively common and inexpensive PPSV23 can decrease the risk of pneumonia and prolong survival., (© 2020 American Cancer Society.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results